4 research outputs found
BINOL-Based Fluorescent Sensor for Recognition of Cu(II) and Sulfide Anion in Water
A multifunctional fluorescent sensor based on a cyclen-appended
BINOL derivative (<b>R-1</b>) was synthesized and characterized.
It can display on–off-type fluorescence change with high selectivity
toward CuÂ(II) among 19 metal ions in 100% aqueous solution. Furthermore,
the in situ generated <b>R-1–CuÂ(II)</b> ensemble could
recover the quenched fluorescence upon the addition of sulfide anion
resulting in a off–on-type sensing with a detection limit of
micromolar range in the same medium. No interference was observed
from other biothiols and anions, including GSH, l-Cys, DTT,
and sulfates, making it a highly sensitive and selective sulfide probe
Fluorescence Imaging of Diabetic Cataract-Associated Lipid Droplets in Living Cells and Patient-Derived Tissues
Diabetic cataract (DC) surgery carries risks such as
slow wound
healing, macular edema, and progression of retinopathy and is faced
with a deficiency of effective drugs. In this context, we proposed
a protocol to evaluate the drug’s efficacy using lipid droplets
(LDs) as the marker. For this purpose, a fluorescent probe PTZ-LD for LDs detection is developed based on the phenothiazine unit.
The probe displays polarity-dependent emission variations, i.e., lower
polarity leading to stronger intensity. Especially, the probe exhibits
photostability superior to that of Nile Red, a commercial LDs staining
dye. Using the probe, the formation of LDs in DC-modeled human lens
epithelial (HLE) cells is validated, and the interplay of LDs–LDs
and LDs-others are investigated. Unexpectedly, lipid transfer between
LDs is visualized. Moreover, the therapeutic efficacy of various drugs
in DC-modeled HLE cells is assessed. Ultimately, more LDs were found
in lens epithelial tissues from DC patients than in cataract tissues
for the first time. We anticipate that this work can attract more
attention to the important roles of LDs during DC progression
Novel Tumor-Specific and Mitochondria-Targeted near-Infrared-Emission Fluorescent Probe for SO<sub>2</sub> Derivatives in Living Cells
Endogenous
sulfur dioxide (SO<sub>2</sub>) is an important gaseous
signal molecule, which was also regarded as one of the reactive sulfur
spaces (RSS) and closely related to cardiovascular diseases and many
neurological disorders. However, the design and synthesis of fluorescent
probes with near-infrared-emission which can detect mitochondrial
SO<sub>2</sub> and its derivatives in living cells still remain unresolved.
Herein, a biotin and coumarin-benzoindole conjugate <b>BCS-1</b> was presented as a ratiometric and colorimetric fluorescent probe
for tracing SO<sub>2</sub> derivatives with excellent selectivity
and rapid responsibility. Notably, it is the first mitochondria-targeted
near-infrared-emission probe that could selectively detect SO<sub>2</sub> in tumor cells. <b>BCS-1</b> could selectively enter
into mitochondria of tumor cells, and the detection limit for SO<sub>2</sub> derivatives was determined as 72 nM
PLK1-Targeted Fluorescent Tumor Imaging with High Signal-to-Background Ratio
As significantly
expressed during cell division, polo-like kinase
1 (PLK1) plays crucial roles in numerous mitotic events and has attracted
interest as a potential therapeutic marker in oncological drug discovery.
We prepared two small molecular fluorescent probes, <b>1</b> and <b>2</b>, conjugated to <b>SBE13</b> (a type II
PLK1 inhibitor) to investigate the PLK1-targeted imaging of cancer
cells and tumors. Enzymatic docking studies, molecular dynamics simulations,
and <i>in vitro</i> and <i>in vivo</i> imaging
experiments all supported the selective targeting and visualization
of PLK1 expressing cells by probes <b>1</b> and <b>2</b>, and probe <b>2</b> was successfully demonstrated to image
PLK1-upregulated tumors with remarkable signal-to-background ratios.
These findings represent the first example of small-molecule based
fluorescent imaging of tumors using PLK1 as a target, which could
provide new avenues for tumor diagnosis and precision therapeutics